A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients

Clinical trial NCT06555068 · RECRUITING

Trial details

NCT number: NCT06555068
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Unresectable or Metastatic Breast Cancer

Start date: 2024-08-12
Primary completion: 2027-12-01
Enrollment: 528

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.